Q1 2026 earnings call recap: record $17.8M revenue, Focal One HIFU growth, guidance reiterated, risks (tariffs/cash).
Edap Tms (NASDAQ:EDAP) reported what management described as a “strong first quarter” for 2026, highlighted by record first-quarter revenue and continued momentum in its high-intensity focused ...
EDAP TMS SA announced preliminary record sales of 11 Focal One Systems in the fourth quarter of 2024, reflecting strong demand for its Focal One Robotic HIFU technology, which is increasingly adopted ...
EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One ® Robotic HIFU in Radiorecurrent Prostate ...
EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue 78% Growth in First Quarter HIFU Revenue ...
Focal One i expands HIFUsion ® patient-specific imaging compatibility to include PSMA PET, ExactVu™ Micro-Ultrasound, along with AI-driven and intelligent algorithms including Unfold AI™ and OnQ™ ...
EDAP TMS (EDAP) announced that its non-invasive, nonsurgical treatment option, Focal One Robotic HIFU, was featured on national television on Friday, September 26, reaching millions of viewers ...
Semi-Live Focal One Procedure to be Conducted on August 15 t h at 5:00 pm (KST) LYON, France, August 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today ...
EDAP TMS SA announced the positive results of its Focal Ablation Versus Radical Prostatectomy (FARP) Study at the AUA Annual Meeting on April 27, 2025. The trial achieved its primary goal, ...